Wouter Hoefsloot

15PUBLICATIONS
20CO-AUTHORS
Computational physiologyMicrobiology not elsewhere classifiedMedical infection agents (incl. prions)Medical bacteriologyNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 10, 2025
Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?

Arthur Lemson, Esmee van der Pol, Jakko van Ingen

|May 02, 2024
Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint.

Jakko van Ingen, Wouter Hoefsloot, Véronique Dartois

|Nov 25, 2021
Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study.

Sanne M H Zweijpfenning, Stephan E P Kops, Martin J Boeree

|Jul 22, 2021
The role of amikacin in the treatment of nontuberculous mycobacterial disease.

Jelmer Raaijmakers, Jodie Anne Schildkraut, Wouter Hoefsloot

|Jul 15, 2021
The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands.

Jodie Anne Schildkraut, Sanne Maria Henriëtte Zweijpfenning, Martijn Nap

|Dec 02, 2020
Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis.

Milou M F Schuurbiers, Mariolina Bruno, Sanne M H Zweijpfenning

Pageof 3

Frequent Collaborators

11 joint publications

Jakko van Ingen

3 joint publications

Mariolina Bruno

1 joint publications

Enrico Tortoli

1 joint publications

Daniela M Cirillo